Bioequivalence and Bioavailability Forum • Quod licet Iovi

Quod licet Iovi [Two-Stage / GS Designs]

posted by mittyri – Russia, 2024-04-05 22:33 (441 d 04:35 ago) – Posting: # 23942
Views: 7,574

Hi Helmut,

❝ the manuscript was not accepted on March 12, 2024. The authors failed to demonstrate that the Type I Error is controlled (see this article why).

Didn't they mention this as a magic bullet argument? ;-)

;-)

—
Kind regards,
Mittyri

Complete thread:

Parallel Group Adaptive Designs Alex 2023-12-22 10:08
- Strong Type I Error control + CI: Not yet… Helmut 2023-12-22 12:01
  - Strong Type I Error control + CI: Not yet… Alex 2024-01-08 16:22
    - Strong Type I Error control + CI: Not yet… Helmut 2024-01-09 09:48
  - Strong Type I Error control + CI: Not yet… roman_max 2024-04-04 15:18
    - Parallel design: Only simulation-based methods so far Helmut 2024-04-04 20:16
      - Parallel design: Only simulation-based methods so far roman_max 2024-04-15 21:46
- Parallel Group Adaptive Designs Achievwin 2024-01-05 11:53
  - Simulations highly recommended Helmut 2024-01-05 12:40
    - Simulations highly recommended Achievwin 2024-01-08 16:55
      - Simulations mandatory Helmut 2024-01-09 09:31
        
        Simulations mandatory Achievwin 2024-01-09 21:11
        
        Reviews are confidential Helmut 2024-01-09 22:10
        
        Reviews are confidential Achievwin 2024-01-19 15:11
        
        Not accepted and for a reason… Helmut 2024-04-04 20:22
        
        Quod licet Iovimittyri 2024-04-05 20:33
        
        Non licet bovi Helmut 2024-04-05 21:50
        
        Non licet bovi mittyri 2024-04-05 22:21
        
        Quod licet bove? Helmut 2024-04-06 07:21

Admin contact
23,424 posts in 4,927 threads, 1,672 registered users;
39 visitors (0 registered, 39 guests [including 8 identified bots]).
Forum time: 03:08 CEST (Europe/Vienna)

Medical researches can be divided into two sorts:
those who think that meta is better and those
who believe that pooling is fooling. Stephen Senn

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC

Ing. Helmut Schütz